Metformin is not associated with improved biochemical free survival or cause-specific survival in men with prostate cancer treated with permanent interstitial brachytherapy

PURPOSE: Several recent studies have suggested improved clinical outcomes in diabetic men with prostate cancer who also use metformin. We explore whether metformin use is associated with improved outcomes specifically in men undergoing prostate brachytherapy. MATERIAL AND METHODS: 2,298 consecutive...

Descripción completa

Detalles Bibliográficos
Autores principales: Taira, Al V., Merrick, Gregory S., Galbreath, Robert W., Morris, Mallory, Butler, Wayne M., Adamovich, Edward
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Termedia Publishing House 2014
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4200187/
https://www.ncbi.nlm.nih.gov/pubmed/25337126
http://dx.doi.org/10.5114/jcb.2014.45757

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4200187/
https://www.ncbi.nlm.nih.gov/pubmed/25337126
http://dx.doi.org/10.5114/jcb.2014.45757

Ejemplares similares